Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma-Reference-Cited by-同舟云学术

Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma

Published:2017-10 Issue:10 Volume:17 Page:650-657
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Barta Stefan K.,Jain Rishi,Mazumder Amithaba,Carter Jason,Almanzar Lawrence,Browne Roy,Shahnaz Samira,Elkind Richard,Kaminetzky David^ORCID,Battini Ramakrishna,Derman Olga,Kornblum Noah,Verma Amit,Braunschweig Ira

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference25 articles.

1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma;Attal;N Engl J Med,1996

2. How I treat multiple myeloma in younger patients;Stewart;Blood,2009

3. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

4. Autologous transplantation and maintenance therapy in multiple myeloma;Palumbo;N Engl J Med,2014

5. Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial;Harousseau;J Clin Oncol,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Busulfan, melphalan and carfilzomib high‐dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma;British Journal of Haematology;2024-01-04

2. Autologous stem cell transplantation in multiple myeloma patients with renal impairment;Annals of Hematology;2023-01-12

3. Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcome;Leukemia & Lymphoma;2022-11-23

4. Chemotherapy and dysphagia: the good, the bad, the ugly;Current Opinion in Otolaryngology & Head & Neck Surgery;2020-10-06

5. Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen;Leukemia & Lymphoma;2020-08-31